of the xeroderma pigmentosum C complementation group, we found unexpectedly that this patient also carried a germline mutation of the INK4a-ARF locus affecting the p16 INK4A reading frame. Three di¡erent somatic mutations that all harbor the signature of ultraviolet light (two of p16 INK4A and one of p53) were also detected in the basal cell carcinoma. We hypothesize that the germline mutation of p16 INK4A , in association with the nucleotide excision repair defect, could explain the patient's unusual phenotype. Furthermore, this study con¢rms that concomitant somatic mutations of INK4a-ARF and p53 occur in some xeroderma pigmentosum associated tumors, and seem to accumulate during tumor progression rather than the initiation step. Key words: lymphoma/mutation/p14 ARF /p16 INK4A /skin carcinogenesis/xeroderma pigmentosum. J Invest Dermatol 119: 1355^1360, 2002 X eroderma pigmentosum (XP) is a rare autosomal recessive disorder associated with a germline nucleotide excision repair (NER) defect (Jung, 1986) . XP patients exhibit an extreme sensitivity to sunlight and an increased frequency of sunlight-induced skin cancers, mainly basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma (Kraemer et al, 1987) . Seven XP complementation groups (A^G) have been distinguished (corresponding to mutations in distinct genes involved in NER), as well as a variant group (XP variant) , which is de¢cient in the mutagenic polymerase Z (Masutani et al, 1999) . The XPC group is the most prevalent complementation group in Europe, United States, and North Africa. XPC cells are exclusively de¢cient in the NER system that corrects the ultraviolet (UV)-induced lesions of the nontranscribed strand (''global genome repair''), but are fully pro¢cient in the transcription coupled repair able to remove speci¢cally UV-induced lesions of the transcribed strand of active genes (Hanawalt, 1994) . Much progress has been made in understanding the process of skin carcinogenesis in XP patients. p53 mutations are the most common genetic alterations, present in more than two-thirds of the tumors (Giglia et al, 1998) . XPC knockout mice are highly predisposed to UVB radiation-induced skin cancer (Sands et al, 1995) , which carry a high proportion of p53 mutations. More recently, a role for the INK4a-ARF locus, which maps to chromosome 9p21 has also been demonstrated in human and murine skin carcinogenesis. This locus gives rise to two alternative transcripts that encode two proteins, p16 INK4a (exons 1a, 2, and 3) and p14 ARF (exons 1b, 2, and 3), both of which are involved in the negative control of cell proliferation (Sharpless and DePinho, 1999) . p16 INK4a is a cyclin-dependent kinase inhibitor that can speci¢cally inhibit progression through the G 1 phase of the replicative cycle in cells that express the retinoblastoma protein, by blocking cyclin-dependent kinase 4 (CDK4) from phosphorylating retinoblastoma protein (Serrano et al, 1993; Ruas and Peters, 1998) . The alternative transcript, p14 ARF , in response to oncogenic signals such as c-myc, E1A, activated Ha-ras, and E2F1, speci¢cally activates the p53 pathway, thereby inducing cell cycle arrest or apoptosis. Activation of p14 ARF results in stabilizing p53 by preventing MDM2-p53 from undergoing ubiquitin-mediated degradation (reviewed in Sherr and Weber, 2000) .
Substantial data now implicate the INK4a-ARF locus in the development of epithelial skin carcinoma. Deletions encompassing this locus are common in SCC lines and in SCC (Loughran et al, 1994) . p16 ink4a is inactivated during keratinocyte immortalization (Loughran et al, 1994; Munro et al, 1999) . Moreover, nullizygous INK4a-ARF (^/^) or speci¢cally ARF (^/^) mice are susceptible to the development of SCC (Serrano et al, 1996; Kamijo et al, 1997) . UV-induced INK4a-ARF mutations have been detected in 12.5% of sporadic epithelial skin tumors (Sou¢r et al, 1999) . XP skin carcinomas show a higher frequency of INK4a-ARF mutations (29% of XP associated skin tumors) that are often multiple and associated in the same tumors with p53 mutations (Sou¢r et al, 2000b) . Little is known, however, about the timing of INK4a-ARF mutation during the multistep process of skin carcinogenesis. To gain insight into the role of this locus in skin carcinogenesis, we performed a molecular analysis of skin tumors, of di¡erent histologic nature or stage, arising in a single XP patient who displays an unusual phenotype. Strikingly, we found that this patient, in addition to belonging to the XPC group, carries a germline mutation on the p16 INK4A gene. This is the ¢rst report of a XPC patient presenting a p16 INK4a germline mutation. Among the tumors, only the BCC carried somatic mutations in INK4a-ARF and p53, suggesting that these modi¢cations occurred late in tumor progression rather than the initiation stage.
MATERIALS AND METHODS
DNA repair analysis and complementation test Unexposed XP skin biopsies were cultured to establish diploid ¢broblast lines and examined for DNA repair level (unscheduled DNA synthesis, UDS) after UVC irradiation as described previously (Sarasin et al, 1992) . In order to con¢rm at the molecular level the diagnosis of XP, and to determine which of the seven XP genes involved in NER is de¢cient in our patient, we carried out genetic complementation of his skin diploid ¢broblasts using infectious retroviral particles expressing the wild-type XP cDNA (Carreau et al, 1995; Zeng et al, 1997) . The level of DNA repair of the patient was quanti¢ed by incorporation of tritiated thymidine (UDS) in the DNA of his skin ¢broblasts after increasing UVC doses.
Analysis of the XPC group by western blotting analysis Protein was extracted in 8 M urea bu¡er as described (Sybert et al, 1985) . Twenty micrograms of protein was run through a 6% acrylamideŝ odium dodecyl sulfate electrophoresis gel and then transferred on to PVDF membrane (Amersham Pharmacia Biotech, Les Ulis, France). Membranes were saturated overnight in phosphate-bu¡ered saline containing 5% nonfat dried milk. The rabbit polyclonal rabbit anti-XPC anti-serum was raised against a carboxy terminal peptide (amino acids 921^940) of the human XPC protein. Working dilution was 1/1000 in saturation solution. As control, membrane were rehybridized using a mouse monoclonal antibody to b-catenin (Clone 14, Transduction Laboratories, Lexington, KY). Blots were revealed using ECL reagents according to the manufacturer's instructions (Amersham Pharmacia Biotech).
Tumor samples, normal skin, and DNA extraction Eight skin neoplasms (four actinic keratosis, two microinvasive SCC, one basal cell carcinoma, and one atypical ¢broxanthoma) from the XP patient were collected following surgical resection. One part was immediately fresh frozen in liquid nitrogen and stored at^801C. A second part was formalin ¢xed and para⁄n embedded, and histopathologic assessment was performed. A biopsy was also obtained of nonsun-exposed normal skin of this XP patient. DNA was prepared from frozen samples as previously described (Daya-Grosjean et al, 1993) .
Single strand conformation polymorphism (SSCP) analysis Coding sequence and £anking intronic sequences of exon 1a, exon 1b, and exon 2 of the INK4a-ARF gene were analyzed by polymerase chain reaction (PCR)-SSCP. Primer sequences for exons 1a and 2 were previously described (Sou¢r Sou¢r et al, 1999 , 2000a . Exon 1b was analyzed through two overlapping PCR products generated by using the following primers: P14F1 5 0 -TCAGGGAAGGGCGGGTGCG-3 0 ; P14R1 5 0 -GCCGCGGGA TGTGAACCA-3 0 (PCR product: 245 bp); P14F2 5 0 -GCCGCGAGT GAGGGTTTT-3 0 ; and P14R2 5 0 -CACCGCGGTTATCTCCTC-3 0 (PCR product 257 bp). Exons 4^9 of p53 gene were ampli¢ed using the same conditions as previously described (Sou¢r et al, 1999) . Total PCR reaction volume was 20 ml, including 50^100 ng of genomic DNA template, 30 pmol of each primer, 0.5 UI (international unit) of Taq polymerase (Gibco-BRL) and 0.1 ml of [a 33 P]deoxycytidine triphosphate (Amersham). Final MgCl 2 concentration was 1.5 mM for all PCR reactions. All reactions were supplemented with 10% dimethyl sulfoxide for optimal PCR ampli¢cation. PCR was processed with an annealing temperature of 601C for the three studied exons of the INK4a-ARF gene, and 551C for exons 4^9 of p53. For SSCP, PCR products were migrated on two 0.1 ÂTBE/ Hydrolink MDE gels (FMC Bioproducts, Tebu, France), with either 8% glycerol at room temperature or without glycerol at þ 41C. Gels were run at 8 W, either 14 h at room temperature or 12 h at 41C, dried, and exposed to autoradiography. The entire procedure was repeated at least twice for each sample. Shifted bands were cut out of the gel, and reampli¢ed using the primers mentioned above.
Sequence analysis Products from 50 ml PCR reactions from reampli¢ed shifted bands and tumoral genomic DNA were puri¢ed using a Microcon 100 (Amicon, Millipore, France) and sequenced using dyelabeled terminator on an automated sequencer 310 (Applied Biosystem, Applera, France) according to the manufacturer's instructions.
RESULTS
Clinical presentation A 12 y old boy from Algeria had typical clinical features of XP (i.e., pronounced photosensibility from the age of 3 y, erythema of photo-exposed skin, poikiloderma, cutaneous xerosis, photophobia, and bilateral conjunctivitis). Starting at the age of 4, multiple skin neoplasms appeared progressively on sun-exposed areas (actinic keratosis, SCC, and BCC).
At the age of 7, the patient presented with acute respiratory syndrome leading to the discovery of a T cell lymphoblastic lymphoma involving the anterior mediastinum, thymus, pericardium, and left pleura. Blood analysis showed 40 Â 10 3 per ml lymphocytes with 50% blasts. Immunotyping revealed that these lymphocytes were CD1a þ , CD4 þ , CD7 þ , CD8 þ , HLADR þ , and weakly CD3 þ . All B markers were negative. A bone marrow analysis showed low cell counts without blasts. Highly carcinogenic drugs (i.e., antracyclins, alkyling agents, or cyclophosphamide) were considered contraindicated in this patient and a milder treatment regimen, including corticosteroids, Aracytin and Purinethol was started and well tolerated. The patient did not receive radiotherapy. After the initiation cure followed by several consolidation cures, the patient was considered in complete remission and has been stable since 1997.
At the age of 10, this patient had two unusual tumors: an atypical ¢broxanthoma localized on the left ear and an epithelioid hemangioma of the neck that were surgically removed.
DNA repair de¢ciency A near to wild-type recovery of UV cell survival was observed solely after transduction of the XPC cDNA (Fig 1) . In contrast, transduction of other XP cDNA (as exempli¢ed in Fig 2 using the XPD cDNA) did not result in the recovery of UV cell survival (Fig 1) . The level of repair defect has been quanti¢ed by UDS after UVC irradiation of the diploid ¢broblasts of the patient, as previously described (Sarasin et al, 1992) . As shown in Fig 2, the UDS level is only 10^15% of our control normal ¢broblast lines and similar to a control XPC ¢broblast line.
This allowed us to conclude that our patient belongs to the XPC group. The patient's ¢broblasts complemented by the wildtype XPC gene exhibit normal UDS (not shown).
Recovery of XPC protein expression in stable XPCtransduced XPC keratinocytes Our complementation data (Figs 1 and 2 ) strongly supported the appartenance of XP208VI to the XPC group. To support further these functional observations, protein extracts were prepared from WT (198VI), XP208VI, and XPC-transduced XP208VI ¢broblasts. A keratinocyte strain, XP148VI, known to express a truncated XPC protein and its XPC-transduced counterpart (Arnaudeau et al, 2002) , were used as control. Protein were processed for western blot analysis using the anti-XPC rabbit anti-serum (Fig 3) . The apparently full length XPC protein (125 kDa) was detected in a WT control cell (198VI) . In contrast, the XPC protein was neither detected in extracts from XP208VI nor, as already shown, in extracts from the XPC control cell strain XP148VI (Arnaudeau et al, 2002) . In both XP cell strains (XP208VI, XP148VI) the absence of XPC protein detection indicated the absence of the XPC epitope recognized by the anti-serum raised against the carboxyterminal part of the XPC protein. On the contrary, XPC-transduced cells, i.e., XP208VI þ XPC and XP148VI þ XPC, expression of the apparently full length XPC protein was recovered as compared with that detected from WT 198VI extracts. As in most other XPC patients studied to date (Chavanne et al, 2000) , the absence of the full length XPC protein in XP208VI cells could be considered as a de¢nitive assignment to the XPC complementation group.
Mutational analysis of the INK4a-ARF locus SSCP analysis revealed abnormal bands for exon 1a only in one tumor (sample 7), the BCC. In exon 2, a common abnormal migration pattern was observed from all DNA analyzed (tumoral, normal skin, and normal ¢broblast cell line), with an additional bandshift in tumor sample 7, the BCC. No abnormal band was seen for exon 1b of p14 ARF . DNA sequencing of abnormal bands revealed three mutations located within the cDNA sequence (Table I and Fig 4) . One was characterized as a germline mutation, as it was present in DNA from all tumoral samples as well as from the patient's normal skin and ¢broblast cell line. This germline mutation was a G4T transversion resulting in a mis-sense mutation in the p16 INK4a reading frame (Ala127Ser). In contrast, this mutation had no consequence on p14 ARF , as it lies outside of its coding sequence ( Table I) . The two other alterations are somatic mutations of the BCC (tumor 7), which are characteristic UV-induced mutations occurring at dipyrimidic sites. One was a C:G4T:A transition located in the 5 0 untranslated sequence of p16 INK4a cDNA, possibly corresponding to a regulatory mutation. The second was a tandem CC:GG4TT:AA transition and corresponds to a known mutational hotspot in XP-associated skin tumors (Sou¢r et al, 2000b) . This mutation also a¡ects the p14 ARF reading frame, at a codon conserved between mouse and human cDNA. The nucleotide composition of this codon (CCC) makes it a prime target for mutagenesis by UV.
Mutational analysis of the p53 gene SSCP analysis revealed a unique bandshift in exon 7 of the p53 gene, in BCC 7, corresponding to a tandem CC:GG4TT:AA transition that resulted in a mis-sense mutation at codon 248 of the p53 Western blot analysis was carried out using protein extracts from XP208VI cells before XP208VI (XPC) and after retroviral transduction (XP208VI+XPC). 198VI (WT control) is a normal ¢broblast strain. XP148VI (XPC) is a keratinocyte strain known to belong to the XPC complementation group. XP148VI+XPC are XP148VI cells following retroviral transduction of XPC (Arnaudeau et al, 2002) . Note that XPC is not detected in extracts from XP148VI and XP208VI (studied patient), whereas the full length protein is re-expressed in transduced cells as in XP198 WT control. The same membrane was stripped and then rehybridized using anti-b-catenin monoclonal to control that similar amounts of protein were present in this area of the membrane. The star indicates a nonspeci¢c band found in any condition. gene ( Table I) . This mutation is a p53 hotspot found predominantly in skin cancers from XP patients (Beroud and Soussi, 1998) .
DISCUSSION
To gain insight into the role of the INK4a-ARF and p53 genes in XP skin carcinogenesis, we performed a molecular analysis of the INK4a-ARF and p53 genes in skin tumors with di¡erent characteristics and stages arising in a single XP patient that displayed a particularly severe phenotype.
Remarkably, our XP patient developed three unusual tumors. To the best of our knowledge, non-Hodgkin lymphoblastic mediastinal lymphoma has never been described in a XP patient (Kraemer et al, 1987) . Epithelioid hemangioendothelioma arising in the skin is extremely rare, and was also not pre-viously described in XP patients (Kraemer et al, 1987) . Atypical ¢broxanthoma is a pleomorphic tumor usually classi¢ed as a distinct subtype of malignant ¢brous histiocytoma that usually occurs on actinically damaged skin in the elderly, only rarely reported in XP patients (Patterson and Jordan, 1987; Dilek et al, 2000) .
Unexpectedly, this patient was found to carry a p16 INK4a germline mutation (Ala127Ser) characterized by its presence in normal skin and a ¢broblast cell line as well as in all the tumor samples analyzed. Several arguments convey toward a pathogenic e¡ect of this mutation. First, this mutation is located in the fourth ankyrin domain of the protein, a domain crucial in p16 INK4a function. Secondly, this mutation was reported as a germline mutation in patients that developed di¡erent types of cancer: melanoma (Gruis et al, 1995) ; lung cancer (Okamoto et al, 1994) ; and primary human esophageal tumors (Zhou et al, 1994; Suzuki et al, 1995) . Furthermore, in Suzuki et al (1995) , this mutation was associated with loss of the normal remaining allele in the esophageal tumor. Ala127Ser was also characterized as an acquired somatic mutation in a SCC of the bladder (Gonzalez-Zulueta et al, 1995) . Some functional studies did not ¢nd any effect of this variant on CDK4 binding (Koh et al, 1995; Ruas et al, 1999) . A recent study, however, reported that testing of p16 INK4a interactions with CDK in protein binding assays is an unreliable predictor of mutant p16 INK4a function in cells (Becker et al, 2001) . Indeed, in one study, this Ala127Ser allele was intermediate in its ability to cause growth cell arrest (Koh et al, 1995) . Altogether, these data indicate that Ala127Ser may be a p16 INK4a germline mutation rather than a polymorphism. In addition, our hypothesis that abrogation of p16 INK4a could probably have contributed to the patient's particularly severe phenotype is reinforced by previous observations. First, germline defects of the INK4a-ARF locus might predispose to hematologic malignancies: (i) a germline mutation of p16 INK4a that was recently shown to predispose a patient to multiple myeloma, which is another hematopoietic disorder (Dilworth et al, 2000) , and (ii) mice nullizygous or heterozygous for the INK4a-ARF locus are highly prone to lymphoid malignancies as well as reticulosarcomas (Kamijo et al, 1997) . Second, inactivation of the INK4a-ARF locus occurs commonly in human lymphoid disorders (Ruas and Peters, 1998) as well as in malignant ¢brous histiocytoma, a tumor histologically related to atypical ¢broxanthoma (Brinck et al, 1998; Simons et al, 2000) .
Three somatic mutations were also detected, one in the p53 gene, and two in the INK4a-ARF gene, that were all found in only one of eight (12.5%) skin tumors. This is an overall low mutation frequency. This contrasts with the high frequency of p53 Table I . The sequence is shown 5 0 -3 0 for the coding strand. The sequence is written 5 0 -3 0 for the coding strand; the mutated base is written in upper case letters. The text in bold indicates nucleotide and amino acid changes. The text in italics, indicates the germline p16 INK4a mutation. Mutations indicated by an asterisk are predicted to be UVB-induced mutations. Mutations on conserved residues of p14 ARF are underlined. mutations detected in normal skin, precancerous, and cancer lesions arising in XP patients (Williams et al, 1998) . This discrepancy may have several explanations. First, it should be noted that all but one tumor (85%) were small lesions; i.e., either precancerous lesions (actinic keratosis in 57% of cases) or microinvasive SCC (in 28% of cases). In line with this, in a previous study, XP skin tumors less than 8 mm in diameter were shown to harbor a signi¢cantly lower frequency of p53 mutation than larger tumors from the same XP patients (Matsumura et al, 1995) . Additionally, our tumor was not microdissected and this could account for a lower sensitivity of mutation detection. Finally, in our particular case, the presence of a p16 INK4a germline mutation could have decreased the need for additional p53 mutations. Moreover, we previously detected INK4a-ARF mutations in only one of six sporadic SCC of early grade (Bowen diseases or actinic keratosis; (Sou¢r et al, 1999) , which correlate with our present results and seem to signify that such mutations occur in the late stage of tumor development.
All three mutations detected in the BCC were characteristic of UV-induced lesions, occurring at dipyrimidinic sites, and located in two cases on the nontranscribed strand of the gene. The third mutation is due to an unrepaired DNA lesion that lies outside the transcribed sequence and therefore is not preferentially repaired. This mutational pattern is highly characteristic of XPC patients, pro¢cient in preferential repair of active transcribed genes (Giglia et al, 1998; Sou¢r et al, 2000b) . It is important to note that mutations of the three genes (p53, p16 INK4a , and p14 ARF ) occurred in the same tumor. This association was previously found in XP tumors (Sou¢r et al, 2000b) , and is probably related to the high genetic instability linked to the DNA repair defect in these patients. The accumulation of unrepaired mutations leads to the preferential selection of tumoral clones sharing inactivation of multiple tumor suppressor pathways.
In conclusion, we show for the ¢rst time that the coexistence of germline inactivation of a DNA repair gene and a cell cycle regulator gene that may have acted in concert to generate cancer proneness in a patient.
